Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
10/2002
10/09/2002WO2001079168A1 Nitrogenous compounds and antiviral drugs containing the same
10/09/2002EP1246837A2 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides
10/09/2002EP1246799A1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/09/2002EP1246798A1 Process for the production of n-methyl pyrrolidone using gamma butyrolactone and mixed methylamines as starting materials
10/09/2002EP1246795A2 Antibacterial agents
10/09/2002EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002EP1246619A1 Urotensin-ii receptor antagonists
10/09/2002EP1133229B1 Fungicides containing pyrrolidones as their active agents
10/09/2002EP0975622B1 Selective olefin metathesis of bifunctional or polyfunctional substrates in compressed carbon dioxide as reaction medium
10/09/2002EP0772590B1 Thrombin inhibitors
10/09/2002CN1373755A Azacycloalkanone serine protease inhibitors
10/09/2002CN1373754A Antibacterial agents
10/09/2002CN1373753A Mutual salt of amlodipine and atorvastatin
10/09/2002CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002CN1373125A Process for preparing D-proline
10/09/2002CN1092193C Prolylendopeptidase inhibitors
10/09/2002CN1092181C Benzyloxy substd, aromatics and their use as fungicides and insecticides
10/09/2002CN1092022C Microbicides
10/09/2002CA2405690A1 Nitrogen-containing compounds and antiviral drugs containing the same
10/08/2002USRE37873 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them
10/08/2002US6462201 Process for the production of N-vinyl-2-pyrrolidone by vinylation
10/08/2002US6462194 2,4-disubstituted pyrrolidine-3-carboxylic acid derivatives
10/08/2002US6462179 Conjugation to peptides, proteins, hormones, polysaccharides, nucleic acids, haptens, drugs, ligands, toxins, halophors, and other macromolecules
10/08/2002US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases
10/08/2002US6462075 Chalcone and its analogs as agents for the inhibition of angiogensis and related disease states
10/08/2002US6462073 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
10/08/2002US6462072 Such as 4,4-diphenylcyclohexl-1-(3,3-dimethyl-2-oxopentan-oyl)-pyrrolidine-2 -carboxylate; rotamase inhibitors; neuronal repair and regrowth; parkinson's disease, alzheimer's disease, amyotrophic lateral sclerosis
10/08/2002US6462057 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
10/08/2002US6462049 Low toxicity and persistent insecticides and fungicides; preventing attachment of aquatic organisms; ecosystem friendly; nonpolluting
10/08/2002US6462048 3-(2-(4-methylpiperazin-1-yl)-benzylidene)-1,3-dihydro-indol-2-one for example; useful as psychotherapeutic agents
10/08/2002US6462044 Therapy for sexual disorders
10/08/2002US6462040 Microbiocides; bacteriocides; antiprotozoa agents; quinolone antibiotics; side effect reduction; antibiotic-resistant bacteria including staphyloccocus; veterinary medicine
10/08/2002US6461391 Primary intermediates for oxidative coloration of hair
10/08/2002CA2145775C 1,4-disubstituted piperazines useful in the therapy of the asthma and of the inflammation of the respiratory tract
10/08/2002CA2095361C Optical isomers of 7-¬3-(1,1-dialkylmethyl-1-amino)-1-pyrrolidinyl|-quinolones and naphthyridones as antibacterial agents
10/08/2002CA2058328C 2-aryl-5-trifluoromethyl)-2-pyrroline compounds useful in the manufacture of insecticidal, nematocidal and acaricidal arylpyrroles
10/03/2002WO2002076978A1 Δ1 pyrrolines
10/03/2002WO2002076965A1 Non peptide mimetics based on the active sequence s42fllr46 of the thrombin receptor for the treatment of thrombosis and cancer
10/03/2002WO2002076945A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002WO2002076944A1 Method of purifying n-(2-hydroxyethyl)-2-pyrrolidone
10/03/2002WO2002076929A1 Aryl and biaryl compounds having mch modulatory activity
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076925A2 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002WO2002076923A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
10/03/2002WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002US20020143191 Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020143003 As serotonin, norepinephrine and dopamine reuptake inhibitors, for therapy of central nervous system and other disorders
10/03/2002US20020142998 For prophylaxis and therapy
10/03/2002US20020142969 Using didepsipeptide for the control of endoparasites in medicine and veterinary medicine
10/03/2002US20020142967 Thrombin inhibitors
10/03/2002US20020142290 Compound for use in the treatment of viral diseases
10/03/2002US20020139657 Method of purifying N-(2-hydroxyethy)-2- pyrrolidone
10/03/2002CA2443289A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
10/03/2002CA2441334A1 .delta.1 pyrrolines
10/03/2002CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002CA2441080A1 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
10/03/2002CA2440389A1 Aminopyrrolidine sulfonamides as serine protease inhibitors
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/02/2002EP1245649A2 Low foam N-alkyltartarimide and N-alkylmalimide wetting agents
10/02/2002EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
10/02/2002EP1245564A1 Benzamidine derivatives
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1244651A1 Diamidine compounds as dna minor groove binders
10/02/2002EP1244624A1 Anthracene derivatives as anti-cancer agents
10/02/2002EP1244621A1 Nitrile derivatives as cathepsin k inhibitors
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002EP1244452A1 Urotensin-ii receptor antagonists
10/02/2002EP0963484B1 Sizing of paper
10/02/2002EP0917529A4 Catalyst compositions and processes for olefin oligomerization and polymerization
10/02/2002EP0915832B1 Boronic compound complexing reagents and highly stable complexes
10/02/2002EP0906279B1 Pyrrole derivatives
10/02/2002DE10113587A1 Verfahren zur Herstellung von substituierten Pyrrolen A process for the preparation of substituted pyrroles
10/02/2002CN1372566A Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/02/2002CN1372558A Intermediates for the production of quinolone carboxylic acid derivatives
10/02/2002CN1372539A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
10/02/2002CN1372458A Oxidation dyeing composition for keratinous fibres and dyeing method using same
10/02/2002CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/02/2002CN1091764C Pesticidal sulfur compounds
10/01/2002US6458982 Transition metal compound, catalyst, its production and its use for the polymerization of olefins
10/01/2002US6458965 Herbicides, antigrowth agents and surfactants for wood preservatives
10/01/2002US6458960 Sulfonamide derivatives
10/01/2002US6458948 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt
10/01/2002US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes
10/01/2002US6458826 A pyrrolidine compound used as repellant for pests, insects, mites and ticks on animals and human
10/01/2002US6458825 Eukaryotic cells contain multiple proteolytic systems, including lysosomal proteases, calpains, atp-ubiquitin-proteasome dependent pathway, and an
10/01/2002US6458806 Aryl alkenamides derivatives as MCP-1 antagonists
10/01/2002US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458779 Treatment of conditions associated with excess production of soluble cd23 (s-cd23) such as autoimmune disease and allergy. the compounds of the invention are also inhibitors of the release of tumour necrosis factor (tnf).
09/2002
09/26/2002WO2002074757A1 Method for producing substituted pyrroles and furans
09/26/2002WO2002074744A1 Oxoammonium salts and the use thereof
09/26/2002WO2002074741A1 Pyrrolidine ester derivatives with oxytocin modulating acitvity
09/26/2002WO2002074740A1 Biguanide derivatives
09/26/2002WO2002074737A2 Process for the preparation of 2-hydroxymethyl-pyrolidine-3,4-diols
09/26/2002WO2002074731A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 404